IBDEI0UV ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14203,2)
 ;;=^5002514
 ;;^UTILITY(U,$J,358.3,14204,0)
 ;;=E08.339^^82^774^38
 ;;^UTILITY(U,$J,358.3,14204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14204,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14204,1,4,0)
 ;;=4^E08.339
 ;;^UTILITY(U,$J,358.3,14204,2)
 ;;=^5002515
 ;;^UTILITY(U,$J,358.3,14205,0)
 ;;=E08.341^^82^774^39
 ;;^UTILITY(U,$J,358.3,14205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14205,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14205,1,4,0)
 ;;=4^E08.341
 ;;^UTILITY(U,$J,358.3,14205,2)
 ;;=^5002516
 ;;^UTILITY(U,$J,358.3,14206,0)
 ;;=E08.349^^82^774^40
 ;;^UTILITY(U,$J,358.3,14206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14206,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14206,1,4,0)
 ;;=4^E08.349
 ;;^UTILITY(U,$J,358.3,14206,2)
 ;;=^5002517
 ;;^UTILITY(U,$J,358.3,14207,0)
 ;;=E09.311^^82^774^31
 ;;^UTILITY(U,$J,358.3,14207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14207,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14207,1,4,0)
 ;;=4^E09.311
 ;;^UTILITY(U,$J,358.3,14207,2)
 ;;=^5002552
 ;;^UTILITY(U,$J,358.3,14208,0)
 ;;=E09.319^^82^774^32
 ;;^UTILITY(U,$J,358.3,14208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14208,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14208,1,4,0)
 ;;=4^E09.319
 ;;^UTILITY(U,$J,358.3,14208,2)
 ;;=^5002553
 ;;^UTILITY(U,$J,358.3,14209,0)
 ;;=E09.321^^82^774^27
 ;;^UTILITY(U,$J,358.3,14209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14209,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14209,1,4,0)
 ;;=4^E09.321
 ;;^UTILITY(U,$J,358.3,14209,2)
 ;;=^5002554
 ;;^UTILITY(U,$J,358.3,14210,0)
 ;;=E09.329^^82^774^28
 ;;^UTILITY(U,$J,358.3,14210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14210,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14210,1,4,0)
 ;;=4^E09.329
 ;;^UTILITY(U,$J,358.3,14210,2)
 ;;=^5002555
 ;;^UTILITY(U,$J,358.3,14211,0)
 ;;=E09.351^^82^774^29
 ;;^UTILITY(U,$J,358.3,14211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14211,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,14211,1,4,0)
 ;;=4^E09.351
 ;;^UTILITY(U,$J,358.3,14211,2)
 ;;=^5002560
 ;;^UTILITY(U,$J,358.3,14212,0)
 ;;=E09.359^^82^774^30
 ;;^UTILITY(U,$J,358.3,14212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14212,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,14212,1,4,0)
 ;;=4^E09.359
 ;;^UTILITY(U,$J,358.3,14212,2)
 ;;=^5002561
 ;;^UTILITY(U,$J,358.3,14213,0)
 ;;=H52.4^^82^775^57
 ;;^UTILITY(U,$J,358.3,14213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14213,1,3,0)
 ;;=3^Presbyopia
 ;;^UTILITY(U,$J,358.3,14213,1,4,0)
 ;;=4^H52.4
 ;;^UTILITY(U,$J,358.3,14213,2)
 ;;=^98095
 ;;^UTILITY(U,$J,358.3,14214,0)
 ;;=H01.004^^82^775^6
 ;;^UTILITY(U,$J,358.3,14214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14214,1,3,0)
 ;;=3^Blepharitis,Left Upper Eyelid,Unspec
 ;;^UTILITY(U,$J,358.3,14214,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,14214,2)
 ;;=^5004241
 ;;^UTILITY(U,$J,358.3,14215,0)
 ;;=H01.005^^82^775^5
 ;;^UTILITY(U,$J,358.3,14215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14215,1,3,0)
 ;;=3^Blepharitis,Left Lower Eyelid,Unspec
